Pregnancy and Childbirth
Conditions
Interventions
Placebo
Sponsors
Dr Iyiola Akeem Adewale
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: • Women who give informed consent • Age of 18 years or older • Nulliparity • Spontaneous onset of labour with cervical dilatation of 4 cm to 5cm • Singleton term gestation ( = 37 weeks of gestation) • A live fetus with cephalic presentation.
Exclusion criteria
Exclusion criteria: • Previous uterine scar • Those with any contraindication to vaginal delivery • Multiple gestation • Spontaneous rupture of membrane before presentation • Hypersensitivity to metoclopramide • Those with medical illness like hypertension, diabetes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome measures will be rate of cervical dilatation per hour and duration of active first stage labour | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures will include duration of second and third stages of labour, intrapartum blood loss, proportion of parturient that required oxytocin augmentation, proportion of parturient that received analgesics and number of times received, APGAR scores at one and five minutes and major maternal drug adverse effects (dystonia, extrapyramidal manifestations, hallucination, visual disturbance, hypersensitivity reaction and skin rash). | — |
Countries
Nigeria
Contacts
Public ContactAkeem Iyiola
Consultant
Outcome results
None listed